Daxor Long Term Debt 2010-2011 | DXR

Daxor long term debt from 2010 to 2011. Long term debt can be defined as the sum of all long term debt fields.
Daxor Annual Long Term Debt
(Millions of US $)
2011 $0
2010 $0
2009 $0
Daxor Quarterly Long Term Debt
(Millions of US $)
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.045B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $18.796B 18.52
Encompass Health (EHC) United States $12.062B 25.57
DaVita (DVA) United States $10.827B 15.22
Elanco Animal Health (ELAN) United States $7.395B 15.84
Chemed (CHE) United States $6.801B 21.38
Option Care Health (OPCH) United States $5.024B 22.39
RadNet (RDNT) United States $4.246B 269.48
Amedisys (AMED) United States $3.209B 21.59
Addus HomeCare (ADUS) United States $2.056B 22.58
LifeStance Health (LFST) United States $1.777B 0.00
Astrana Health (ASTH) United States $1.408B 34.89
U.S Physical Therapy (USPH) United States $1.121B 28.93
Pennant (PNTG) United States $0.874B 32.09
Aveanna Healthcare Holdings (AVAH) United States $0.794B 45.22
Atai Life Sciences (ATAI) Germany $0.545B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00